Eligibility Schizophrenia NCT01516424

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
subject met dsm-iv-tr criteria for a primary diagnosis of schizophrenia
Description

ID.1

Type de données

boolean

patients are 18≤age≤65 years of age on the day when informed consent is obtained.
Description

ID.2

Type de données

boolean

subject had a panss total score ≥70 and 120≥ at screening
Description

ID.3

Type de données

boolean

subject had a score ≥4 on the panss at screening and baseline.
Description

ID.4

Type de données

boolean

subjects are willing and able to comply with study protocol including treatment in hospital.
Description

ID.5

Type de données

boolean

subjects or their legal guardians have signed the written informed consent form.
Description

ID.6

Type de données

boolean

Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
the subject was treatment with other investigate product within 30 days.
Description

ID.7

Type de données

boolean

subject had a history of treatment with long-acting drug for anti schizophrenia within 56 days.
Description

ID.8

Type de données

boolean

subject had a history of treatment with clozapine within 28 days.
Description

ID.9

Type de données

boolean

subject with parkinson disease,etc
Description

ID.10

Type de données

boolean

Similar models

Eligibility Schizophrenia NCT01516424

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
subject met dsm-iv-tr criteria for a primary diagnosis of schizophrenia
boolean
ID.2
Item
patients are 18≤age≤65 years of age on the day when informed consent is obtained.
boolean
ID.3
Item
subject had a panss total score ≥70 and 120≥ at screening
boolean
ID.4
Item
subject had a score ≥4 on the panss at screening and baseline.
boolean
ID.5
Item
subjects are willing and able to comply with study protocol including treatment in hospital.
boolean
ID.6
Item
subjects or their legal guardians have signed the written informed consent form.
boolean
Item Group
C0680251 (UMLS CUI)
ID.7
Item
the subject was treatment with other investigate product within 30 days.
boolean
ID.8
Item
subject had a history of treatment with long-acting drug for anti schizophrenia within 56 days.
boolean
ID.9
Item
subject had a history of treatment with clozapine within 28 days.
boolean
ID.10
Item
subject with parkinson disease,etc
boolean